title: The non-canonical IκB kinases IKKε and TBK1 as potential targets for the development of novel therapeutic drugs.
abstract: IκB kinase epsilon (IKKε) and TANK-binding kinase 1 (TBK1) are two non-canonical IKKs which are involved in interferon regulatory factor (IRF) as well as nuclear factor kappaB (NF-κB) signaling cascades. Both kinases have already been linked to the pathophysiology of several diseases and therefore been suggested as potential promising targets for the development of therapeutic drugs. In this review, we summarize the roles of IKKε and TBK1 in different diseases and outline therapeutic options for modulation of these kinases.
authors.affiliation: Pharmazentrum frankfurt/ZAFES, Institut für Klinische Pharmakologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Theodor Stern Kai 7, D-60590 Frankfurt am Main, Germany. e.niederberger@em.uni-frankfurt.de
authors.forename: E
authors.initials: E
authors.lastname: Niederberger
authors.forename: C V
authors.initials: CV
authors.lastname: Möser
authors.forename: K L
authors.initials: KL
authors.lastname: Kynast
authors.forename: G
authors.initials: G
authors.lastname: Geisslinger
mesh_terms: D006801:Humans; D051550:I-kappa B Kinase / Q000235:genetics / Q000378:metabolism*; D058990:Molecular Targeted Therapy; D016328:NF-kappa B / Q000378:metabolism; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D016328:NF-kappa B; D017346:Protein Serine-Threonine Kinases; C403191:TBK1 protein, human; D051550:I-kappa B Kinase